Drug Shortage Report for PROTAMINE SULFATE INJECTION USP
| Report ID | 268027 |
| Drug Identification Number | 02231674 |
| Brand name | PROTAMINE SULFATE INJECTION USP |
| Common or Proper name | PROTAMINE SULFATE INJECTION USP |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | PROTAMINE SULFATE |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 25ML 1LIVI |
| ATC code | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2025-09-26 |
| Estimated end date | 2025-10-10 |
| Actual end date | 2025-10-03 |
| Shortage status | Resolved |
| Updated date | 2025-10-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-10-04 | English | Compare |
| v4 | 2025-10-03 | French | Compare |
| v3 | 2025-10-03 | English | Compare |
| v2 | 2025-09-29 | French | Compare |
| v1 | 2025-09-29 | English | Compare |
Showing 1 to 5 of 5